Jeffrey Jonas possesses extensive experience in the pharmaceutical and biotechnology industries, serving in high-level roles across various companies. Notable positions include Chief Medical Officer and Vice President of Clinical Development at Upjohn from 1991 to 1996, and currently, Chairman at Kenai Therapeutics since March 2024. Jeffrey has held leadership positions such as Chief Executive Officer at ABio-X and President of Shire Regenerative Medicine. With an educational background including an MD from Harvard Medical School and a BA in Biology/English from Amherst College, Jeffrey also directs multiple organizations, including Noema Pharma, Generation Bio, Compass Pathways, and serves as a partner at Cure Ventures.
This person is not in any teams
This person is not in any offices